Deprecated: Creation of dynamic property lastRSS::$cache_dir is deprecated in /www/wwwroot/name104.com/00rss.php on line 45
Deprecated: Creation of dynamic property lastRSS::$cache_sqlite is deprecated in /www/wwwroot/name104.com/00rss.php on line 46
Deprecated: Creation of dynamic property lastRSS::$cache_time is deprecated in /www/wwwroot/name104.com/00rss.php on line 47
Deprecated: Creation of dynamic property lastRSS::$rsscp is deprecated in /www/wwwroot/name104.com/lastRSS.php on line 234
- Fulgent Genetics - Leader in Next Generation Sequencing
Fulgent is an accredited leader in clinical diagnostic genetic sequencing
- CCL16 Single Gene - Fulgent Genetics
Sequence variants and or copy number variants (deletions duplications) within the CCL16 gene will be detected with >99% sensitivity Variants classified as unknown significance (VUS), likely pathogenic, or pathogenic will be reported Benign and like
- Known Mutation Testing - Fulgent Genetics
This testing is appropriate for targeted mutation analysis of the biological parents to determine whether they share the same variant (s) as a relative who has already been tested (the proband) previously at Fulgent This test can analyze only variants of uncertain significance (VUS) as identified in the proband This test is only available as complimentary, no-cost Familial Known Mutation
- Prenatal Testing - Fulgent Genetics
By performing diagnostic testing on a prenatal sample, Fulgent can help identify whether an individual's baby could be at risk for a suspected genetic condition The results of this testing may assist a patient and provider make informed decisions regarding pregnancy management, delivery planning, and postnatal care
- Ming Hsieh | Executives | Fulgent Genetics
The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts
- Overview | Fulgent Genetics
The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts
- Erythromelalgia (SCN9A Single Gene Test) - Fulgent Genetics
This is a next generation sequencing (NGS) test appropriate for individuals with clinical signs and symptoms, suspicion of, or family history of Erythromelalgia Sequence variants and or copy number variants (deletions duplications) within the SCN9A
|